Drug Type Therapeutic radiopharmaceuticals |
Synonyms 3BP-Delta-like Ligand-3(3B Pharmaceuticals), Small Cell Lung Cance (3B Pharmaceuticals) |
Target |
Action modulators |
Mechanism DLL3 modulators(Delta-like protein 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Small Cell Lung Cancer | Preclinical | Germany | 22 Jun 2024 |





